Norges Bank Uro Gen Pharma Ltd. Transaction History

Norges Bank

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2020 Feb 10, 2021	SELL	$17.54 - $25.43 $789,300 - $1.14 Million	-45,000 Closed	0 $0
Q3 2020 Nov 12, 2021	BUY	$18.81 - $26.42 $846,450 - $1.19 Million	45,000 New	45,000 $868,000
Q3 2020 Nov 10, 2020	SELL	$18.81 - $26.42 $846,450 - $1.19 Million	-45,000 Closed	0 $0
Q2 2020 Aug 13, 2021	BUY	$16.5 - $29.7 $742,500 - $1.34 Million	45,000 New	45,000 $1.18 Million
Q2 2019 Aug 09, 2019	SELL	$32.75 - $40.35 $982,500 - $1.21 Million	-30,000 Closed	0 $0
Q1 2019 May 11, 2020	BUY	$35.47 - $54.55 $1.06 Million - $1.64 Million	30,000 New	30,000 $1.11 Million
Q1 2018 May 09, 2018	SELL	$38.64 - $57.54 $51,545 - $76,758	-1,334 Closed	0 $0
Q4 2017 Mar 05, 2018	BUY	$27.28 - $43.26 $36,391 - $57,708	1,334 New	1,334 $50,000
Q4 2017 Feb 09, 2018	SELL	$27.28 - $43.26 $36,391 - $57,708	-1,334 Closed	0 $0
Q3 2017 Nov 13, 2018	BUY	$17.15 - $32.72 $22,878 - $43,648	1,334 New	1,334 $42,000
Q3 2017 Nov 07, 2017	SELL	$17.15 - $32.72 $512,784 - $978,328	-29,900 Closed	0 $0
Q2 2017 Jul 24, 2018	BUY	N/A	29,900	29,900 $540,000

120

39.3M

158K

161K

Ticker URGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 22,740,500
Market Cap $282M
Description
UroGen Pharma Ltd., a biotechnology company, engages in the development and commercialization novel solutions for specialty cancers and urothelial diseases. It offers RTGel, a polymeric biocompatible and reverse thermal gelation hydrogel to improve therapeutic profiles of existing drugs; and Jelmyto for pyelocalyceal solution. The company's lead...

Get notified when there are updates to the investment portfolio of Norges Bank, based on Form 13F filings with the SEC.

Stay updated on Norges Bank with notifications on news.